Survival advantage in black versus white men with CKD

Effect of estimated GFR and case mix

Csaba Kovesdy, Leigh Quarles, Evan H. Lott, Jun Ling Lu, Jennie Z. Ma, Miklos Z. Molnar, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Black dialysis patients have significantly lower mortality compared with white patients, in contradistinction to the higher mortality seen in blacks in the general population. It is unclear whether a similar paradox exists in patients with non-dialysis-dependent chronic kidney disease (CKD), and if it does, what its underlying reasons are. Study Design: Historical cohort. Setting & Participants: 518,406 white and 52,402 black male US veterans with non-dialysis-dependent CKD stages 3-5. Predictor: Black race. Outcomes & Measurements: We examined overall and CKD stage-specific all-cause mortality using parametric survival models. The effect of sociodemographic characteristics, comorbid conditions, and laboratory characteristics on the observed differences was explored in multivariable models. Results: During a median follow-up of 4.7 years, 172,093 patients died (mortality rate, 71.0 [95% CI, 70.6-71.3] per 1,000 patient-years). Black race was associated with significantly lower crude mortality (HR, 0.95; 95% CI, 0.94-0.97; P < 0.001). The survival advantage was attenuated after adjustment for age (HR, 1.14; 95% CI, 1.12-1.16), but was magnified after full multivariable adjustment (HR, 0.72; 95% CI, 0.70-0.73; P < 0.001). The unadjusted survival advantage of blacks was more prominent in those with more advanced stages of CKD, but CKD stage-specific differences were attenuated by multivariable adjustment. Limitations: Exclusively male patients. Conclusions: Black patients with CKD have lower mortality compared with white patients. The survival advantage seen in blacks is accentuated in patients with more advanced stages of CKD, which may be explained by changes in case-mix and laboratory characteristics occurring during the course of kidney disease.

Original languageEnglish (US)
Pages (from-to)228-235
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume62
Issue number2
DOIs
StatePublished - Aug 1 2013

Fingerprint

Diagnosis-Related Groups
Chronic Renal Insufficiency
Survival
Mortality
hydroquinone
Kidney Diseases
Veterans
Dialysis
Cohort Studies

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Survival advantage in black versus white men with CKD : Effect of estimated GFR and case mix. / Kovesdy, Csaba; Quarles, Leigh; Lott, Evan H.; Lu, Jun Ling; Ma, Jennie Z.; Molnar, Miklos Z.; Kalantar-Zadeh, Kamyar.

In: American Journal of Kidney Diseases, Vol. 62, No. 2, 01.08.2013, p. 228-235.

Research output: Contribution to journalArticle

Kovesdy, Csaba ; Quarles, Leigh ; Lott, Evan H. ; Lu, Jun Ling ; Ma, Jennie Z. ; Molnar, Miklos Z. ; Kalantar-Zadeh, Kamyar. / Survival advantage in black versus white men with CKD : Effect of estimated GFR and case mix. In: American Journal of Kidney Diseases. 2013 ; Vol. 62, No. 2. pp. 228-235.
@article{43d1cac1f1e649e7b631dd26e77bf0a5,
title = "Survival advantage in black versus white men with CKD: Effect of estimated GFR and case mix",
abstract = "Background: Black dialysis patients have significantly lower mortality compared with white patients, in contradistinction to the higher mortality seen in blacks in the general population. It is unclear whether a similar paradox exists in patients with non-dialysis-dependent chronic kidney disease (CKD), and if it does, what its underlying reasons are. Study Design: Historical cohort. Setting & Participants: 518,406 white and 52,402 black male US veterans with non-dialysis-dependent CKD stages 3-5. Predictor: Black race. Outcomes & Measurements: We examined overall and CKD stage-specific all-cause mortality using parametric survival models. The effect of sociodemographic characteristics, comorbid conditions, and laboratory characteristics on the observed differences was explored in multivariable models. Results: During a median follow-up of 4.7 years, 172,093 patients died (mortality rate, 71.0 [95{\%} CI, 70.6-71.3] per 1,000 patient-years). Black race was associated with significantly lower crude mortality (HR, 0.95; 95{\%} CI, 0.94-0.97; P < 0.001). The survival advantage was attenuated after adjustment for age (HR, 1.14; 95{\%} CI, 1.12-1.16), but was magnified after full multivariable adjustment (HR, 0.72; 95{\%} CI, 0.70-0.73; P < 0.001). The unadjusted survival advantage of blacks was more prominent in those with more advanced stages of CKD, but CKD stage-specific differences were attenuated by multivariable adjustment. Limitations: Exclusively male patients. Conclusions: Black patients with CKD have lower mortality compared with white patients. The survival advantage seen in blacks is accentuated in patients with more advanced stages of CKD, which may be explained by changes in case-mix and laboratory characteristics occurring during the course of kidney disease.",
author = "Csaba Kovesdy and Leigh Quarles and Lott, {Evan H.} and Lu, {Jun Ling} and Ma, {Jennie Z.} and Molnar, {Miklos Z.} and Kamyar Kalantar-Zadeh",
year = "2013",
month = "8",
day = "1",
doi = "10.1053/j.ajkd.2012.12.012",
language = "English (US)",
volume = "62",
pages = "228--235",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Survival advantage in black versus white men with CKD

T2 - Effect of estimated GFR and case mix

AU - Kovesdy, Csaba

AU - Quarles, Leigh

AU - Lott, Evan H.

AU - Lu, Jun Ling

AU - Ma, Jennie Z.

AU - Molnar, Miklos Z.

AU - Kalantar-Zadeh, Kamyar

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Background: Black dialysis patients have significantly lower mortality compared with white patients, in contradistinction to the higher mortality seen in blacks in the general population. It is unclear whether a similar paradox exists in patients with non-dialysis-dependent chronic kidney disease (CKD), and if it does, what its underlying reasons are. Study Design: Historical cohort. Setting & Participants: 518,406 white and 52,402 black male US veterans with non-dialysis-dependent CKD stages 3-5. Predictor: Black race. Outcomes & Measurements: We examined overall and CKD stage-specific all-cause mortality using parametric survival models. The effect of sociodemographic characteristics, comorbid conditions, and laboratory characteristics on the observed differences was explored in multivariable models. Results: During a median follow-up of 4.7 years, 172,093 patients died (mortality rate, 71.0 [95% CI, 70.6-71.3] per 1,000 patient-years). Black race was associated with significantly lower crude mortality (HR, 0.95; 95% CI, 0.94-0.97; P < 0.001). The survival advantage was attenuated after adjustment for age (HR, 1.14; 95% CI, 1.12-1.16), but was magnified after full multivariable adjustment (HR, 0.72; 95% CI, 0.70-0.73; P < 0.001). The unadjusted survival advantage of blacks was more prominent in those with more advanced stages of CKD, but CKD stage-specific differences were attenuated by multivariable adjustment. Limitations: Exclusively male patients. Conclusions: Black patients with CKD have lower mortality compared with white patients. The survival advantage seen in blacks is accentuated in patients with more advanced stages of CKD, which may be explained by changes in case-mix and laboratory characteristics occurring during the course of kidney disease.

AB - Background: Black dialysis patients have significantly lower mortality compared with white patients, in contradistinction to the higher mortality seen in blacks in the general population. It is unclear whether a similar paradox exists in patients with non-dialysis-dependent chronic kidney disease (CKD), and if it does, what its underlying reasons are. Study Design: Historical cohort. Setting & Participants: 518,406 white and 52,402 black male US veterans with non-dialysis-dependent CKD stages 3-5. Predictor: Black race. Outcomes & Measurements: We examined overall and CKD stage-specific all-cause mortality using parametric survival models. The effect of sociodemographic characteristics, comorbid conditions, and laboratory characteristics on the observed differences was explored in multivariable models. Results: During a median follow-up of 4.7 years, 172,093 patients died (mortality rate, 71.0 [95% CI, 70.6-71.3] per 1,000 patient-years). Black race was associated with significantly lower crude mortality (HR, 0.95; 95% CI, 0.94-0.97; P < 0.001). The survival advantage was attenuated after adjustment for age (HR, 1.14; 95% CI, 1.12-1.16), but was magnified after full multivariable adjustment (HR, 0.72; 95% CI, 0.70-0.73; P < 0.001). The unadjusted survival advantage of blacks was more prominent in those with more advanced stages of CKD, but CKD stage-specific differences were attenuated by multivariable adjustment. Limitations: Exclusively male patients. Conclusions: Black patients with CKD have lower mortality compared with white patients. The survival advantage seen in blacks is accentuated in patients with more advanced stages of CKD, which may be explained by changes in case-mix and laboratory characteristics occurring during the course of kidney disease.

UR - http://www.scopus.com/inward/record.url?scp=84880634785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880634785&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2012.12.012

DO - 10.1053/j.ajkd.2012.12.012

M3 - Article

VL - 62

SP - 228

EP - 235

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 2

ER -